Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002129840 | SCV002407447 | benign | not provided | 2023-12-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003307966 | SCV004002778 | likely benign | Inborn genetic diseases | 2023-06-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV002129840 | SCV004128513 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | VPS13D: BP4, BS2 |
Breakthrough Genomics, |
RCV002129840 | SCV005282491 | benign | not provided | criteria provided, single submitter | not provided |